News | November 21, 2025
Piramal Pharma Solutions’ UK facility bags updated MHRA GMP certification
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
The issue comprises a fresh issue of Rs. 95 crore and targeting a total raise of around Rs. 895 crore
Both companies will jointly execute development and scale-up of multiple strategic APIs, including late-stage NCE-1 opportunities
Under the agreement, Evonik will distribute InVitria’s blood-free rHSA portfolio to its biopharma customers
This move positions the U.S.-based consumer healthcare company for a significantly larger role in the rapidly expanding at-home and retail diagnostic testing market
Conjugated Estrogens Tablets are indicated for moderate to severe menopausal symptoms, including hot flashes, and for the prevention of postmenopausal osteoporosis in women at significant risk
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
With US$ 30.46 billion in exports and robust manufacturing capabilities, the industry is poised to expand into high-value drugs while strengthening ESG and compliance standards
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
The observations are procedural in nature and will be responded to within the stipulated time
Subscribe To Our Newsletter & Stay Updated
